| 29 June 2017 | Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.
| Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al. |
| 30 July 2020 | Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
| Livingston, G; Huntley, J; Sommerlad, A; et al. |
| 1 May 2017 | Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.
| Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al. |
| 1 February 2018 | Effectiveness of Monitoring, Managerial Entrenchment, and Corporate Liquidity
| Couzoff, P; Banerjee, S; Pawlina, G |
| 19 September 2016 | Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD - a factorial cluster randomised controlled trial
| Ballard, C; Orrell, M; Sun, Y; et al. |
| 3 October 2023 | Information complementarities and the dynamics of transparency shock spillovers
| Banerjee, S; Dasgupta, S; Shi, R; et al. |
| 22 February 2018 | A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025
| Pickett, J; Bird, C; Ballard, C; et al. |
| 29 September 2021 | Structural basis for UFM1 transfer from UBA5 to UFC1
| Kumar, M; Padala, P; Fahoum, J; et al. |
| 15 July 2020 | What works in managing complex conditions in older people in primary and community care? A state-of-the-art review
| Frost, R; Rait, G; Wheatley, A; et al. |
| 4 February 2019 | The WNK-SPAK/OSR1 kinases and the cation-chloride cotransporters as therapeutic targets for neurological diseases
| Huang, H; Song, S; Banerjee, S; et al. |
